News Archives

  • 5 questions for … Dr. Ana Florea

    May 4, 2021
    Ana Florea, PhD, MPH, is an epidemiologist and post-doctoral research fellow with the Department of Research & Evaluation at Kaiser Permanente Southern California. She has special interests in vaccine safety and effectiveness, infectious diseases, cancer, and chronic kidney diseases. Currently, she is involved in projects studying shingles and Tdap vaccines. She works on projects involving ...
    Read more...
  • New Kaiser Permanente COVID-19 Vaccine Side Effect Monitoring System launches

    April 28, 2021
    A pilot program in Southern California will develop a vaccine side effect monitor that provides real-time insights to researchers and public health officials.
    Read more...
  • Child vaccination rates recovering since pandemic’s early days

    April 15, 2021
    The numbers of recommended vaccine doses, including measles vaccine, administered to children decreased dramatically after the declaration of a national state of emergency on March 13, 2020, due to the COVID-19 pandemic, according to a Kaiser Permanente study published in Pediatrics. While the decrease was lower and recovered in children under 2 years of age, ...
    Read more...
  • Physical activity may reduce risk of poor COVID-19 outcomes

    April 14, 2021
    A Kaiser Permanente study of nearly 50,000 people with COVID-19 suggested that regular physical activity provided strong protection from hospitalization, intensive care unit admission, and death. Even exercising inconsistently lowered the odds for severe COVID-19 outcomes when compared to people who were not active at all. The study, led by investigators in Kaiser Permanente Southern California, ...
    Read more...
  • Most patients’ end-of-life care wishes are met

    April 6, 2021
    The vast majority of patients make their end-of-life care wishes known to loved ones, and nearly 90% of the time those wishes were carried out according to Kaiser Permanente research published April 6, 2021, in the medical journal JAMA Network Open. “There is a common perception that people don’t often document or tell others about their ...
    Read more...
  • KPSC teams with Moderna, Pfizer-BioNTech to assess real-world effectiveness of COVID-19 vaccines

    March 30, 2021
    Researchers from Kaiser Permanente Southern California are collaborating with Moderna and Pfizer-BioNTech, the makers of the 2 first authorized COVID-19 vaccines, to study their vaccines’ effectiveness in real-world settings in preventing the disease and reducing its severity. Questions these studies will evaluate range from how long protection lasts to how well vaccines perform against variants ...
    Read more...
  • New CIRT research projects aim to improve care

    March 30, 2021
    The Care Improvement Research Team has awarded funds for 7 new research projects led by Southern California Permanente Medical Group scientists and physician researchers on COVID-19 and other health topics to help improve the care physicians provide for their patients. “This kind of research provides important new evidence to our frontline clinicians,” said Nancy Gin, MD, ...
    Read more...
  • 5 questions for … Dr. Shireen Fatemi

    March 30, 2021
    Shireen Fatemi, MD, FACE, FACP, is an endocrinologist at the Kaiser Permanente Panorama City Medical Center. She was recently named the 2020 Southern California Permanente Medical Group Physician Researcher of the Year. Dr. Fatemi is the chief of Endocrinology in the Department of Internal Medicine and former assistant area medical director at Panorama City. She ...
    Read more...